Skip to main content

Welcome to Health-NCP-Net 3.0 (HNN 3.0)

We are a network of National Contact Points (NCPs) in the area of “Health” enhancing transnational cooperation between NCPs for Cluster 1 Health in Horizon Europe to increase the support for those interested in research funding.

The HNN 3.0 Team wishes you a joyful holiday season and a great start into the New Year.

Services

You are a Health-NCP and are looking for support and advice for your daily work. Here you can find the support services and activities offered by the Health-NCP-NET.

Events & Calls

You need to get an overview of all the health calls and interesting international health events. Here you will find a sorted list of EU-related calls and events from the health sector.

Funding Opportunities

You are a researcher , a research entity or company and interested in European funding opportunities for research and innovation projects. Here you can learn more about open calls in the different programs/ pillars of Horizon Europe, and other programs relevant to health research.

News

Work programme 2025 of the Health Cluster and the Cancer Mission pre-published
28.04.2025

The European Commission has pre-published the Horizon Europe work programmes for all programme parts with calls for proposals for 2025. They can be found on the European Commission website.

The Health Cluster's work program is divided into three calls, which will open on the Funding and Tenders Portal on May 22, 2025. The electronic submission system and all required documents will be available there at that time.

The Cancer Mission's work program includes two separate calls for proposals. The calls will open on May 6, 2025, in the Funding and Tenders Portal.

EU rules on medical devices and in vitro diagnostics –feedback open
13.01.2025

The Commission would like to hear your views.

Feedback period:
12 December 2024 - 21 March 2025  (midnight Brussels time)

Feedback received will be published on this site and therefore must adhere to the feedback rules.

Regulations 2017/745 and 2017/746 on medical devices and in vitro diagnostics aim to ensure the availability of safe and effective devices. This should protect patient safety and public health while making the sector more competitive and supporting innovation.

The targeted evaluation will help the Commission take stock and assess whether the rules:

  • are effective, efficient and proportionate
  • meet current and emerging needs
  • align with other actions
  • have EU added value.

EU website

The Commission and Switzerland complete negotiations to bring the EU-Switzerland bilateral relationship to a new level
13.01.2025

On 20 December, the President of the European Commission Ursula von der Leyen and the President of the Swiss Confederation Viola Amherd confirmed the completion of negotiations on a broad package of agreements that aim to deepen and expand the EU-Switzerland relationship.

The broad package includes a wide range of elements:

  • The update of five agreements which already give Switzerland access to the EU internal market – air transport, land transport, the free movement of persons, conformity assessment and trade in agricultural products. Bringing these agreements to a modern standard will enable citizens and businesses on both sides to fully benefit from the rights they provide and will create a level playing field for business.

EC website
Swiss website

The new von der Leyen Commission started working on 1 December
12.12.2024

Ekaterina Zaharieva is the new Commissioner for Startups, Research and Innovation and oversees the Directorate General for Education and Research and the Joint Research Center.

The Commission President emphasizes that Ekaterina Zaharieva will play a crucial role in closing the innovation gap with the US and China by strengthening Europe's competitiveness. Research, innovation, science and technology should be placed at the heart of the economy and it should be ensured that small companies and startups in Europe can also develop in order to bring more groundbreaking technologies from the laboratory to the market.

More on EC Website

Publication of the SRIA of the new partnership "BrainHealth"
15.11.2024

The coordinating and supporting action for the new European Health Partnership "Brain Health" has published the Strategic Research and Innovation Agenda (SRIA). The SRIA is a partnership`s strategy document, which identifies its objectives, impact areas and expected outcomes.

See SRIA

Experts wanted for network for clinical trials for children's medicines
29.10.2024

Conect4children is a pan-European network with the aim of supporting the development of new therapies for the pediatric population in Europe. The network advocates for children's health by providing strategic feasibility advice to pharmaceutical companies and academic consortia involved in pediatric drug research.

Conect4children has been building a network of experts for six years, including from the areas of methodology, clinics and patients/parents, in order to process specific inquiries from the pharmaceutical industry and academic projects. Additional clinical pediatric experts are currently being sought. Through their membership in the c4c network, the experts will contribute to strategic feasibility advice and ensure that new therapies are well suited for the pediatric population. Interested experts in pediatric drug research can submit their applications by November 8, 2024.

Conect4children Website

Events & Calls

Colour legend:
Call Event

Supporting initiatives and collaborations

See all the supporting initiatives and collaborations of HNN 3.0

Sign up for our newsletter

For detailed information about our privacy practices, please click here.
You can unsubscribe at any time by clicking the link in the footer of our emails.

GDPR
In accordance with GDPR which harmonizes the rules on personal protection and the handling of personal information throughout Europe. In order to enforce this regulation, we would like to ask you to confirm that you want to receive information from us by email.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.